These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1004677

  • 1. [Amitriptyline in the treatment of anxiety and insomnia anal as a tranquilizer].
    Díaz Solano C.
    Neurol Neurocir Psiquiatr; 1976; 17(3):133-8. PubMed ID: 1004677
    [Abstract] [Full Text] [Related]

  • 2. [Amitriptyline hydrochloride in the treatment of anxiety and insomnia and as a tranquilizer].
    Aurón Zaltzman D.
    Neurol Neurocir Psiquiatr; 1976; 17(3):165-9. PubMed ID: 1004682
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of etizolam in patients with anxiety and insomnia].
    Crea L, Aguglia E.
    Riv Eur Sci Med Farmacol; 1988 Jun; 10(3):253-7. PubMed ID: 3274718
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
    Mendels J.
    J Clin Psychiatry; 1994 Feb; 55(2):60-5. PubMed ID: 7915708
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of limbitrol and amitriptyline on sleep efficiency and architecture.
    Scharf MB, Hirschowitz J, Zemlan FP, Lichstein M, Woods M.
    J Clin Psychiatry; 1986 Dec; 47(12):587-91. PubMed ID: 3536890
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the effectiveness of temazepam on the insomnia of patients with neurosis and endogenous depression.
    Maggini C, Murri M, Sacchetti G.
    Arzneimittelforschung; 1969 Oct; 19(10):1647-52. PubMed ID: 4311716
    [No Abstract] [Full Text] [Related]

  • 7. Early morning insomnia and daytime anxiety--a multicentre general practice study comparing loprazolam and triazolam.
    Moon CA, Ankier SI, Hayes G.
    Br J Clin Pract; 1985 Sep; 39(9):352-8. PubMed ID: 2865963
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical effect of nitrazepam on psychoneurosis with insomnia].
    Kaneko J, Takaishi N, Ida H, Abe H, Hosaka M.
    Saishin Igaku; 1969 Oct; 24(10):2142-8. PubMed ID: 4900118
    [No Abstract] [Full Text] [Related]

  • 9. [Therapy of the primary symptom anxiety in neuroses, abnormal experience reactions, neuro-vegative psychosomatic disorders and depressions].
    Guthy H, Hildgen J, Brinkmann G.
    Arzneimittelforschung; 1971 Jul; 21(7):1095-7. PubMed ID: 5109351
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of amitriptyline in the treatment of psychogenic disorders].
    De Rentería CD.
    Neurol Neurocir Psiquiatr; 1976 Jul; 17(3):149-63. PubMed ID: 1004680
    [Abstract] [Full Text] [Related]

  • 11. [Clinical observation of a new anxiolytic phenothiazine derivative].
    Vieira JC.
    Hospital (Rio J); 1970 Oct; 78(4):1147-53. PubMed ID: 5313973
    [No Abstract] [Full Text] [Related]

  • 12. [Authors' own clinical evaluation of the effect of reladorm].
    Landowski J, Nowicki Z.
    Psychiatr Pol; 1978 Oct; 12(4):469-77. PubMed ID: 31646
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical trial of a new tranquilizing agent: trioxazine].
    Taverna P, Ferrari G.
    Minerva Med; 1970 Jun 09; 61(46):2574-90. PubMed ID: 5425739
    [No Abstract] [Full Text] [Related]

  • 14. [Betamed in the treatment of psychogenic disorders with a somatic component].
    Jellinger K.
    Wien Med Wochenschr; 1983 Sep 30; 133(18):463-7. PubMed ID: 6359726
    [Abstract] [Full Text] [Related]

  • 15. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression].
    Bernardi F, Cairoli S, D'Aurizio C, De Rosa A, Grasso A, Sannino V, Savoldi F, Sorge F, Casadei GL.
    Minerva Psichiatr; 1988 Sep 30; 29(4):203-10. PubMed ID: 3074234
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical trial of bromazepam in psychiatric hospital practice (author's transl)].
    Brunner H, Patris MF.
    Nouv Presse Med; 1982 May 13; 11(22):1695-8. PubMed ID: 6124935
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of anxiety with bromazepam in clinical practice (author's transl)].
    Bornstein S, Benoudich H, Kaufman E, Konqui M, Pigeon P.
    Nouv Presse Med; 1982 May 13; 11(22):1731-4. PubMed ID: 6124945
    [Abstract] [Full Text] [Related]

  • 18. [Clinical trial of bromazepam. Thirty-four cases (author's transl)].
    Horseau C, Brion S.
    Nouv Presse Med; 1982 May 13; 11(22):1741-3. PubMed ID: 6124948
    [Abstract] [Full Text] [Related]

  • 19. [Anxiety in ambulatory and hospital practice: effects of a new anxiolytic agent, bromazepam, in a homogeneous series of 30 patients (author's transl)].
    Billé J, Dalmas C.
    Nouv Presse Med; 1982 May 13; 11(22):1706-9. PubMed ID: 6124938
    [Abstract] [Full Text] [Related]

  • 20. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J, Saletu B, Linzmayer L, Böck G, Weissgram S, Brandstaätter N, Frey R, Saletu-Zyhlarz G.
    Methods Find Exp Clin Pharmacol; 1997 Nov 13; 19(9):645-54. PubMed ID: 9500129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.